HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Liesbeth M Kager Selected Research
Liesbeth M Kager Research Topics
Disease
10
Melioidosis
01/2015 - 02/2010
10
Sepsis (Septicemia)
11/2014 - 02/2010
8
Infections
01/2015 - 02/2012
7
Inflammation (Inflammations)
01/2015 - 03/2010
5
Tuberculosis (Tuberculoses)
10/2017 - 08/2012
4
Pneumonia (Pneumonitis)
05/2014 - 03/2010
2
Pulmonary Tuberculosis
10/2017 - 12/2015
2
Pneumococcal Pneumonia
11/2014 - 05/2014
1
Pain (Aches)
01/2021
1
Neuralgia (Stump Neuralgia)
01/2021
1
Pancreatitis
01/2020
1
Typhoid Fever (Typhoid)
01/2018
1
Asthma (Bronchial Asthma)
12/2015
1
Osteomyelitis
05/2014
1
Tuberculoma
05/2014
1
Cholecystitis
02/2012
1
Cholangitis
02/2012
1
Multiple Myeloma
01/2009
Drug/Important Bio-Agent (IBA)
6
Protein C
IBA
12/2015 - 04/2013
5
Cytokines
IBA
05/2014 - 08/2012
3
Anticoagulants
IBA
01/2018 - 11/2014
3
Proteins (Proteins, Gene)
FDA Link
12/2015 - 03/2010
3
Endothelial Protein C Receptor
IBA
05/2014 - 01/2013
3
Thrombomodulin
IBA
04/2014 - 02/2014
2
Lectins
IBA
03/2014 - 02/2014
1
Opioid Analgesics (Opioids)
IBA
01/2021
1
Triglycerides (Triacylglycerol)
IBA
01/2020
1
Calcium
IBA
01/2020
1
Alanine Transaminase (SGPT)
IBA
01/2020
1
Nucleosomes (Nucleosome)
IBA
10/2017
1
Leukocyte Elastase (Neutrophil Elastase)
IBA
10/2017
1
Pancreatic Elastase (Elastase)
IBA
10/2017
1
Triggering Receptor Expressed on Myeloid Cells-1
IBA
12/2015
1
drotrecogin alfa activated (Xigris)
FDA Link
12/2015
1
Granzymes (Granzyme)
IBA
09/2015
1
Lipopolysaccharides
IBA
01/2015
1
Biological Warfare Agents
IBA
01/2015
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2015
1
Pharmaceutical Preparations
IBA
11/2014
1
Paraffin
IBA
05/2014
1
Acids
IBA
05/2014
1
Peptide Hydrolases (Proteases)
FDA Link
02/2014
1
Anti-Inflammatory Agents (Anti-Inflammatories)
IBA
01/2013
1
Glyburide (Glibenclamide)
FDA Link
Generic
01/2013
1
Tuberculin (PPD)
IBA
08/2012
1
Plasminogen Activator Inhibitor 1
IBA
08/2012
1
Plasminogen Inactivators
IBA
08/2012
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
07/2012
1
Anti-Bacterial Agents (Antibiotics)
IBA
02/2012
1
Hemostatics (Antihemorrhagics)
IBA
03/2010
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
03/2010
1
Urokinase Plasminogen Activator Receptors
IBA
03/2010
1
Messenger RNA (mRNA)
IBA
03/2010
1
Macrophage Migration-Inhibitory Factors
IBA
02/2010
1
Antibodies
IBA
02/2010
1
Proteasome Inhibitors
IBA
01/2009
1
Bortezomib (Velcade)
FDA Link
01/2009
Therapy/Procedure
1
Length of Stay
01/2020
1
Intravenous Administration
07/2013
1
Drug Therapy (Chemotherapy)
01/2013
1
Antibiotic Prophylaxis
02/2012